Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-04-09-Speech-3-365"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-04-09"^^xsd:date2
dcterms:Is Part Of	lp_eu:Human tissues and cells2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20030409.7.3-365"2
lpv:hasSubsequent	lp_eu:2003-04-09-Speech-3-3662
lpv:speaker	lp:John Bowis2
lpv:spoken text	"Mr President, first of all, let me join the rapporteur in welcoming this report from the Commission. It is an important measure to regulate the quality, safety and procedures for cells and tissues used for transplants. The key is the protection of human health. I echo the Commissioner's words in congratulating the rapporteur, Mr Liese, who has ably steered a path, strengthening the protection of human health, ensuring informed consent and avoiding most of the pitfalls of previous debates in this area of human endeavour. When I see amendments put down and signed in the names of both Mr Liese and Mr Nisticò, I know that this is a measure where there has been enormous effort to bring about a meeting of minds and views. That will stand this measure in good stead. The Commission proposal was a good one but perhaps could be improved. The report to Parliament introduces improvements in some areas but perhaps left some issues needing clarification. Some of the changes may be unhelpful. The new amendments, such as the one excluding industry to which the Commissioner referred when he talked about industry's fears that trading activities might be affected or constrained, are also to be welcomed. I acknowledge that there is an issue over the Amendment 7, which included research in the scope of the directive. One could express mild surprise that it was deemed to be in order. It certainly exercised health charities and researchers. We need to consider whether it has a place in this measure or not. On the other hand there are issues that need to be clarified in the way that this measure does. We should not include organs in this measure on cells and tissues. Organs are for another day. Equally, this is not the time to permit cloned human embryos or hybrid human animal embryos to have their cells and tissues used for transplants. The demise of Matilda, the Australian sheep which disintegrated, serves as an awful warning that this is a very young area of science and experiment and, leaving aside the ethical issues, one that should not be permitted now, simply on the grounds of the potential severe and uncertain impact on human health. Another issue is the question of remunerated donation. It is a problem that arose in Mr Nisticò's report on blood. It was recognised then that we have different traditions and needs. Voluntary donation is preferable but not always possible. We will have to look again at this to see if we can find a form of words that will cover our many traditions and needs. I suspect that we will end up not a million miles from the excellent formula that Mr Nisticò incorporated in his blood and blood products directive."@en1
lpv:spokenAs	unknown; Conservative and Unionist Party (1999-07-20--2004-07-19)3 member; Committee on Development and Cooperation (2002-05-30--2004-07-19)3 vice-chair; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees and Delegation for relations with Tadjikistan, Turkmenistan and Mongolia (2002-02-07--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 member; EPP-ED (1999-07-20--2004-07-19)3 member; Members from the European Parliament to the Joint Parliamentary Assembly of the Agreement between the African, Caribbean and Pacific States and the European Union (ACP-EU) (2002-02-06--2004-07-19)3
lpv:unclassifiedMetadata	"Bowis (PPE-DE )."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph